Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial

被引:0
|
作者
Nicola Ruperto
Daniel Lovell
Pierre Quartier
Angelo Ravelli
Mahinda Karunaratne
Jasmina Kalabic
Anabela Cardoso
Alberto Martini
Gerd Horneff
机构
[1] PRINTO-IRCCS,PRCSG
[2] Cincinnati Children's Hospital Medical Center,undefined
[3] Hopital Necker-Enfants Malades,undefined
[4] Istituto G. Gaslini and Università degli Studi di Genova,undefined
[5] AbbVie Inc.,undefined
[6] AbbVie Deutschland GmbH & Co. KG,undefined
[7] AbbVie,undefined
[8] Asklepios Klinik Sankt Augustin,undefined
关键词
Juvenile Idiopathic Arthritis; Adalimumab; Normal Function; Health Assessment Questionnaire; Questionnaire Disability;
D O I
10.1186/1546-0096-12-S1-P9
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] TREATING TO TARGET OF MINIMAL DISEASE ACTIVITY AND NORMAL FUNCTION IN POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS WITH ADALIMUMAB: ANALYSIS FROM A PHASE 3 CLINICAL TRIAL
    Ruperto, N.
    Lovell, D.
    Quartier, P.
    Ravelli, A.
    Karunaratne, M.
    Kalabic, J.
    Cardoso, A.
    Martini, A.
    Horneff, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 130 - 131
  • [2] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
    De Benedetti, F.
    Ruperto, N.
    Zuber, Z.
    Keane, C.
    Harari, O.
    Kenwright, A.
    Cuttica, R.
    Keltsev, V.
    Xavier, R.
    Calvo, I.
    Nikishina, I.
    Rubio-Perez, N.
    Alekseeva, E.
    Chasnyk, V.
    Chavez, J.
    Horneff, G.
    Opoka-Winiarska, V.
    Quartier, P.
    Silva, C.
    Silverman, E.
    Spindler, A.
    Martini, A.
    Lovell, D.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70
  • [3] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
    Brunner, Hermine
    Ruperto, Nicolino
    Zuber, Zbigniew
    Keane, Caroline
    Harari, Olivier
    Kenwright, Andrew
    Cuttica, Ruben J.
    Keltsev, Vladimir
    Xavier, Ricardo
    Penades, Inmaculada Calvo
    Nikishina, Irina
    Rubio-Perez, Nadina
    Alekseeva, Ekaterina
    Chasnyk, Vyacheslav
    Chavez, Jose
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Silva, Clovis A.
    Silverman, Earl D.
    Spindler, Alberto
    Lovell, D. J.
    Martini, Alberto
    De Benedetti, Fabrizio
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682
  • [4] MINIMAL DISEASE ACTIVITY IN A CLINICAL COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE CHILDHOOD ARTHRITIS PROSPECTIVE STUDY
    McErlane, Flora
    Beresford, Michael
    Baildam, Eileen
    Chieng, S. E.
    Davidson, Joyce
    Foster, Helen E.
    Gardner-Medwin, Janet
    Lunt, Mark
    Wedderburn, Lucy
    Thomson, Wendy
    Hyrich, Kimme
    [J]. RHEUMATOLOGY, 2013, 52 : 119 - 120
  • [5] Growth during Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial.
    Bharucha, Kamal N.
    Brunner, Hermine I.
    Ruperto, Nicola
    Cabral, David A.
    Gedalia, Abraham
    Gerloni, Valeria
    Jorgensen, Christian
    Ramanan, Athimalaipet
    Lovell, Daniel
    Martini, Alberto
    Frane, James
    Wells, Chris
    De Benedetti, Fabrizio, Sr.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S117 - S117
  • [6] Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis
    Swart, Joost F.
    van Dijkhuizen, E. H. Pieter
    Wulffraat, Nico M.
    de Roock, Sytze
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (03) : 336 - 342
  • [7] Health-Related Quality of Life, Physical Function, Fatigue, and Disease Activity in Children with Established Polyarticular Juvenile Idiopathic Arthritis
    Ringold, Sarah
    Wallace, Carol A.
    Rivara, Frederick P.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1330 - 1336
  • [8] Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
    Bharucha, Kamal N.
    Brunner, Hermine I.
    Calvo Penades, Inmaculada
    Nikishina, Irina
    Rubio-Perez, Nadina
    Oliveira, Sheila
    Kobusinska, Katarzyna
    Schmeling, Heinrike
    Sztajnbok, Flavio
    Weller-Heinemann, Frank
    Zholobova, Elena
    Zulian, Francesco
    Allen, Roger
    Chaitow, Jeffrey
    Frane, James
    Wells, Chris
    Ruperto, Nicolino
    De Benedetti, Fabrizio
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1173 - 1179
  • [9] Rheumatoid Factor Status as a Predictor of Disease Activity and Disability: An Analysis of the New CARRA Registry Polyarticular Juvenile Idiopathic Arthritis Cohort
    Balmuri, Nayimisha
    Soulsby, William
    Cooley, Victoria
    Gerber, Linda
    Lawson, Erica
    Onel, Karen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 513 - 516
  • [10] Associations Between the American College of Rheumatology Pediatric Response Measures and the Continuous Measures of Disease Activity Used in Adult Rheumatoid Arthritis A Secondary Analysis of Clinical Trial Data From Children With Polyarticular-Course Juvenile Idiopathic Arthritis
    Ringold, Sarah
    Chon, Yun
    Singer, Nora G.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (12): : 3776 - 3783